Clinical Trial Update: Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the role of N-acetylcysteine (NAC) in patients with cT0 muscle-invasive bladder cancer following maximal TURBT, currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Regina Elena Cancer Institute | Conditions: Muscle-Invasive Bladder Carcinoma, Chemotherapy Effect | Phase 3 | Status: ACTIVE_NOT_RECRUITING